Immunogenicity of an Inactivated COVID-19 Vaccine
Clinical trial NCT05198336 · COMPLETED
Trial details
- NCT number
- NCT05198336
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-08
- Primary completion
- 2022-01-24
- Enrollment
- 395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.